Furthermore, the stronger impact of MET on glucose metabolism compared to EMPA in our study may be attributed to MET's direct effects on insulin sensitivity, a mechanism that may be more relevant in the HFpEF model, which shares metabolic abnormalities with type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.